ResMed Management Performance

ResMed -- USA Stock  

USD 98.80  1.57  1.56%

Analysis of ResMed manpower and management performance can provide insight into ResMed stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with ResMed future performance. Additionally take a look at Your Equity Center.

ResMed Management Effectiveness

The company has Return on Asset of 9.1 % which means that on every $100 spent on asset it made $9.1 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 15.29 % implying that it generated $15.29 on every 100 dollars invested.

ResMed Profit Margins

The company has Net Profit Margin of 12.98 % which may imply that it executes well on its competitive polices and has a good control over its expenditures and variable costs. This is very large. In the same way, it shows Net Operating Margin of 28.09 % which entails that for every 100 dollars of revenue it generated 0.28 of operating income.

ResMed Insider Trading

ResMed Benchmark Summation

ResMed Stakeholders

Michael Farrell CEO and Director, MBA
Peter Farrell Non-Executive Chairman of the Board, Ph.D
Rob Douglas President COO
Jim Hollingshead President - Americas, Ph.D
Don Darkin President - Sleep-disordered Breathing Strategic Business Unit
Anne Reiser President Europe
Raj Sodhi President ? Software as a Service (SaaS) Business and CTO, MBA
Richard McHale President ? Respiratory Care
Donald Darkin President ? innovation & operations
Brett Sandercock CFO and Principal Accounting Officer
Robert Douglas Pres and COO
John Wareham Independent Director, MBA
Ronald Taylor Lead Independent Director
Christopher Roberts Independent Director, MBA
Gary Pace Independent Director, Ph.D
Chris Roberts Independent Director, MBA
Agnes Lee Senior Director - Investor Relations
Carol Burt Independent Director
Rich Sulpizio Independent Director
Ron Taylor Lead Independent Director
Jack Wareham Independent Director
Karen Drexler Director
Richard Sulpizio Independent Director
David Pendarvis Chief Admin. Officer, Global General Counsel and Secretary

Leadership

ResMed Top Executives
Michael Farrell  CEO
CEO and Director
Peter Farrell  Chairman
Non-Executive Chairman of the Board

Tenure Analysis

ResMed Employment Tenure
ResMed employes about 6000 people. The company is managed by 24 executives with total tenure of roughly 157 years, averanging almost 6.0 years of service per executive having 250.0 employee per reported executive.

Earnings

ResMed Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.7April 25, 2017
ResMed normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Manpower Efficiency

Return on ResMed Manpower
Revenue Per Employee 410.9 K
Revenue Per Executive 91.7 M
Net Income Per Employee 78.8 K
Net Income Per Executive 11.9 M
Working Capital Per Employee 130.3 K
Working Capital Per Executive 32.6 M

Per Employee

ResMed Per Employee Growth Over Time

Net Income Per Employee

Revenue Per Employee

Number of Employees

ResMed Number of Employees Analysis
ResMed is rated below average in number of employees category among related companies. The total workforce of Medical Equipment industry is at this time estimated at about 146,523. ResMed holds roughly 6,000 in number of employees claiming about 4% of all equities under Medical Equipment industry.
Additionally take a look at Your Equity Center. Please also try My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. macroaxis watchlist is based on self-learning algorithm to remember stocks you like.